Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $26,961 - $45,319
711 Added 2.93%
24,946 $951,000
Q2 2022

Aug 12, 2022

BUY
$47.98 - $62.75 $39,343 - $51,455
820 Added 3.5%
24,235 $1.32 Million
Q1 2022

May 09, 2022

BUY
$49.85 - $96.11 $54,037 - $104,183
1,084 Added 4.85%
23,415 $1.46 Million
Q4 2021

Feb 10, 2022

BUY
$77.3 - $105.0 $133,574 - $181,440
1,728 Added 8.39%
22,331 $2.25 Million
Q3 2021

Nov 09, 2021

SELL
$74.87 - $110.87 $9,807 - $14,523
-131 Reduced 0.63%
20,603 $1.85 Million
Q2 2021

Aug 12, 2021

BUY
$66.8 - $100.45 $521,040 - $783,510
7,800 Added 60.31%
20,734 $1.91 Million
Q1 2021

May 12, 2021

SELL
$59.3 - $183.85 $2.72 Million - $8.44 Million
-45,886 Reduced 78.01%
12,934 $1.25 Million
Q4 2020

Feb 12, 2021

SELL
$31.01 - $52.1 $899,662 - $1.51 Million
-29,012 Reduced 33.03%
58,820 $3.07 Million
Q3 2020

Nov 12, 2020

SELL
$15.89 - $50.51 $1.23 Million - $3.91 Million
-77,431 Reduced 46.85%
87,832 $3.52 Million
Q2 2020

Aug 04, 2020

SELL
$8.89 - $18.28 $5,831 - $11,991
-656 Reduced 0.4%
165,263 $2.64 Million
Q1 2020

May 04, 2020

SELL
$6.75 - $19.75 $318,181 - $930,975
-47,138 Reduced 22.12%
165,919 $1.79 Million
Q4 2019

Feb 10, 2020

BUY
$9.29 - $15.82 $839,955 - $1.43 Million
90,415 Added 73.72%
213,057 $2.75 Million
Q3 2019

Oct 22, 2019

SELL
$5.96 - $12.81 $191,667 - $411,956
-32,159 Reduced 20.77%
122,642 $1.27 Million
Q2 2019

Aug 15, 2019

BUY
$4.93 - $7.5 $318,344 - $484,297
64,573 Added 71.57%
154,801 $1.03 Million
Q1 2019

May 15, 2019

BUY
$3.47 - $6.05 $26,882 - $46,869
7,747 Added 9.39%
90,228 $537,000
Q4 2018

Feb 06, 2019

BUY
$3.12 - $4.09 $257,340 - $337,347
82,481 New
82,481 $261,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $513M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.